Further examination of immunosuppressant-related gene expression in PRAD samples based on MAP7D3 expression levels revealed marked differences in the expression of 22 immunosuppressant-related genes (Figure 7D). This evidence concerns the gene MAP7D3 and prostate adenocarcinoma.